Association of Glucagon-Like Peptide-1 Receptor Agonist with Progression to Liver Cirrhosis and Alcohol-Related Admissions in Patients with Alcohol Use Disorder and Diabetes: A Retrospective Cohort Study
- 13 April 2025
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 85 (6) , 813-825
Abstract
Aim In recent years, use of glucagon-like peptide-1 receptor agonists (GLP-1RA) has exponentially increased due to their beneficial effects on weight loss and cardiovascular outcomes. Lately, some animal studies and observational data suggested that GLP-1RA may be useful in the treatment of alcohol use disorder (AUD). We aim to compare the risk of progression to liver cirrhosis and alcohol-related hospital admission after initiation of GLP-1RA versus dipeptidyl peptidase-4 inhibitors (DPP4i), as the active comparator, in patients with type 2 diabetes mellitus and AUD. Methods We conducted a retrospective propensity score-matched cohort study, utilizing new-user and active comparator design. The study used data from the Veterans Health Administration during fiscal years 2006 to 2021 encompassing adults with AUD who initiated either GLP-1RA or DPP4i prescriptions. Our two co-primary outcomes were progression to cirrhosis (compensated and decompensated cirrhosis) and alcohol-related hospital admission. Results The eligible cohort included 9965 GLP-1RA users and 19,688 DPP4i users. After propensity score matching, 7302 pairs were matched on 79 characteristics without residual imbalances. In the propensity score-matched cohort, progression to cirrhosis occurred in 6.6% of GLP-1RA users and 6.0% DPP4i users; odds ratio (OR): 1.1, 95% confidence interval (95% CI): 0.97–1.26. Alcohol-related hospital admission occurred in 1.4% of GLP-1RA users and in 1.7% of DPP4i users (OR: 0.85; 95% CI: 0.65–1.11). Conclusions Use of GLP-1RA in patients with AUD was not associated with beneficial effect on progression to cirrhosis or alcohol-related hospital admission.Keywords
Funding Information
- U.S. Department of Veterans Affairs
- HCA Healthcare
This publication has 47 references indexed in Scilit:
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2010
- Negative ControlsEpidemiology, 2010
- Alcohol‐related cirrhosis—early abstinence is a key factor in prognosis, even in the most severe casesAddiction, 2009
- Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialtyDrug and Alcohol Dependence, 2009
- DPP-4 inhibitorsBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- Improved Comorbidity Adjustment for Predicting Mortality in Medicare PopulationsHealth Services Research, 2003
- Effects of ethanol consumption on hepatic hemodynamics in patients with alcoholic cirrhosisGastroenterology, 1997
- Human stomach alcohol and aldehyde dehydrogenases: Comparison of expression pattern and activities in alimentary tractGastroenterology, 1997
- Rate of increase of plasma drug level influences subjective response in humansPsychopharmacology, 1992
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992